Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids

Infection and Immunity

Volumn 66, Issue 9, 1998, Pages 4193-4202

  Wang, Ruobing ^a,b   Doolan, Denise L ^a,g   Charoenvit, Yupin ^a   Hedstrom, Richard C ^a   Gardner, Malcolm J ^a,h   Hobart, Peter ^c   Tine, John ^d   Sedegah, Martha ^a,e   Fallarme, Victoria ^a,b   Sacci Jr , John B ^a,e   Kaur, Manjit ^a   Klinman, Dennis M ^f   Hoffman, Stephen L ^a   Weiss, Walter R ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c VICAL INC   (United States)

^d Virogenetics Corporation   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^g QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^h J CRAIG VENTER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MALARIA VACCINE; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA POLYMORPHISM; EFFECTOR CELL; IMMUNIZATION; LIVER CELL; MALARIA; MONKEY; NONHUMAN; PLASMID; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031691783     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/.66.9.4193-4202.1998     Document Type: Article

References (60)

1. Aidoo, M., M. R. C. P. Lalvani, C. E. M. Allsopp, M. Plebanski, S. J. Meisner, P. Krausa, M. Browning, S. Morris-Jones, S. McAdam, F. Gotch, D. A. Fidock, M. Takiguchi, K. J. H. Robson, B. M. Greenwood, P. Druihle, H. C. Whittle, and A. V. S. Hill. 1995. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 345:1003-1007.
2. Andersson, S., B. Makitalo, R. Thorstensson, G. Franchini, J. Tartaglia, K. Limbach, E. Paoletti, P. Putkonen, and G. Biberfeld. 1996. Immunogenicity and protective efficacy of a human immunodeficiency virus type 2 recombinant canarypox (ALVAC) vaccine candidate in cynomolgus monkeys. J. Infect. Dis. 174:977-985.
3. Boyer, J. D., K. E. Ugen, B. Wang, M. Agadjanyan, L. Gilbert, M. L. Bagarazzi, M. Chattergoon, P. Frost, A. Javadian, W. V. Williams, Y. Refaeli, R. B. Ciccarelli, D. McCallus, L. Coney, and D. Weiner. 1997. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3:526-532.
4. Campbell, J. R. 1989. DNA sequence of the gene encoding a Plasmodium falciparum malaria candidate vaccine antigen. Nucleic Acids Res. 17:5854.
5. Charoenvit, Y., M. L. Leef, L. F. Yuan, M. Sedegah, and R. L. Beaudoin. 1987. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect. Immun. 55:604-608.
6. Davis, H. L., M. J. McCluskie, J. L. Gerin, and R. H. Purcell. 1996. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl. Acad. Sci. USA 93:7213-7218.
7. Doolan, D. L., and S. L. Hoffman. 1997. Multi-gene vaccination against malaria: a multistage, multi-immune response approach. Parasitol. Today 13: 171-178.
8. Doolan, D. L., R. A. Houghten, and M. F. Good. 1991. Location of human cytotoxic T cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein. Int. Immunol. 3:511-516.
9. Doolan, D. L., C. Khamboonruang, H. P. Beck, R. A. Houghten, and M. F. Good. 1993. Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants. Int. Immunol. 5:37-46.
10. Doolan, D. L., A. J. Saul, and M. F. Good. 1992. Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development. Infect. Immun. 60:675-682.
11. + T cell-, interferon-γ-, and nitric oxide-dependent immunity. J. Exp. Med. 183:1739-1746.
12. Doolan, D. L., B. Wizel, and S. L. Hoffman. 1996. Class I HLA-restricted cytotoxic T lymphocyte responses against malaria - elucidation on the basis of HLA peptide binding motif. Immunol. Res. 15:280-305.
13. Doolan, L. D., S. L. Hoffman, S. Southwood, P. A. Wentworth, J. Sidney, R. W. Chesnut, E. Keogh, E. Appella, T. B. Nutman, D. M. Gordon, A. Oloo, A. A. Lal, and A. Sette. 1997. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and -B supertype alleles. Immunity 7:97-112.
14. Fuller, D. H., M. Murphey-Corb, J. Clements, S. Barnett, and J. R. Haynes. 1996. Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination. J. Med. Primatol. 25:236-241.
15. Good, M. F. 1994. Antigenic diversity and MHC genetics in sporozoite immunity. Immunol. Lett. 41:95-98.
16. Gramzinski, R. A., D. C. Maris, N. Obaldia, R. Rossan, M. Sedegah, R. Wang, P. Hobart, M. Margalith, and S. L. Hoffman. 1996. Optimization of antibody responses of a malaria DNA vaccine in Aotus monkeys. Vaccine Res. 5:173-183.
17. Hartikka, J., M. Sawdey, F. Cornefert-Jensen, M. Margalith, K. Barnhart, M. Nolasco, L. Vahlsing, J. Meek, M. Marquet, P. Hobart, J. Norman, and M. Manthorpe. 1996. An improved plasmid expression vector for direct injection into skeletal muscle. Hum. Gene Ther. 7:1205-1217.
18. Hedstrom, R. C., D. L. Doolan, R. Wang, A. Kumar, J. B. Sacci, Jr., M. J. Gardner, J. C. Aguiar, Y. Charoenvit, M. Sedegah, J. Tine, M. Margalith, P. Hobart, and S. L. Hoffman. In vitro expression and in vivo immunogenicity of Plasmodium falciparum prerythrocytic stage DNA vaccines. Int. J. Mol. Med., in press.
19. Hill, A. V. S., J. Elvin, A. C. Willis, M. Aidoo, C. E. Allsopp, F. M. Gotch, X. M. Gao, M. Takiguchi, B. M. Greenwood, A. R. Townsend, et al. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434-439.
20. Hoffman, S. L., J. M. Crutcher, S. K. Puri, A. A. Ansari, F. Villinger, E. D. Franke, P. P. Singh, F. Finkelman, M. K. Gately, G. P. Dutta, and M. Sedegah. 1997. Sterile protection of monkeys against malaria after administration of interleukin-12. Nat. Med. 3:80-83.
21. Hoffman, S. L., E. D. Franke, M. R. Hollingdale, and P. Druilhe. 1996. Attacking the infected hepatocyte, p. 35-75. In S. L. Hoffman (ed.), Malaria vaccine development: a multi-immune response approach. American Society for Microbiology, Washington, D.C.
22. Hoffman, S. L., D. Isenbarger, G. W. Long, M. Sedegah, A. Szarfman, L. Waters, M. R. Hollingdale, P. H. van der Miede, D. S. Finbloom, and W. R. Ballou. 1989. Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 244:1078-1081.
23. Hoffman, S. L., and L. H. Miller. 1996. Perspectives on malaria vaccine development, p. 1-13. In S. L. Hoffman (ed.), Malaria vaccine development: a multi-immune response approach. American Society for Microbiology, Washington, D.C.
24. Lalvani, A., N. Hurt, M. Aidoo, P. Kibatala, M. Tanner, and A. V. S. Hill. 1996. Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania. Eur. J. Immunol. 26:773-779.
25. Lanar, D. E., J. A. Tine, C. D. Taisne, M. C. Seguin, W. I. Cox, J. P. Winslow, L. A. Ware, E. B. Kauffman, D. Gordon, W. R. Ballou, E. Paoletti, and J. C. Sadoff. 1996. Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria. Infect. Immun. 64:1666-1671.
26. Laube, L. S., M. Burrascano, C. E. Dejesus, B. D. Howard, M. A. Johnson, W. T. Lee, A. E. Lynn, G. Peters, G. S. Ronlov, and K. S. Townsend. 1994. Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins. Hum. Gene Ther. 5:853-862.
27. Le, T. P., L. W. Preston Church, G. Corradin, R. L. Hunter, Y. Charoenvit, R. Wang, P. De la Vega, J. Sacci, W. R. Ballou, G. M. Glenn, R. L. Richards, C. R. Alving, and S. L. Hoffman. 1998. Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants. Vaccine 16:305-312.
28. Lu, S., J. Arthos, D. C. Montefiori, Y. Yasutomi, K. Manson, F. Mustafa, E. Johnson, J. C. Santoro, J. Wissink, J. I. Mullins, J. R. Haynes, N. L. Letvin, M. Wyand, and H. L. Robinson. 1996. Simian immunodeficiency' virus DNA vaccine trial in macaques. J. Virol. 70:3978-3991.
29. Luke, C. J., K. Carner, X. Liang, and A. G. Harbour. 1997. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J. Infect. Dis. 175:91-97.
30. Malik, A., J. E. Egan, R. A. Houghton, J. C. Sadoff, and S. L. Hoffman. 1991. Human cytotoxic T lymphocytes against Plasmodium falciparum circumsporozoite protein. Proc. Natl. Acad. Sci. USA 88:3300-3304.
31. + cytotoxic T lymphocytes. J. Exp. Med. 176:1739-1744.
32. 30a. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
33. Raz, E., D. A. Carson, S. E. Parker, T. B. Parr, A. M. Abai, G. Aichinger, S. H. Gromkowski, M. Singh, D. Lew, M. E. Yankauckas, S. M. Baird, and G. H. Rhodes. 1994. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91:9519-9523.
34. Robson, K. J., J. R. Hall, M. W. Jennings, T. J. Harris, K. Marsh, C. I. Newbold, V. E. Tate, and D. J. Weatherall. 1988. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 335:79-82.
35. Rogers, W. O., A. Malik, S. Mellouk, K. Nakamura, M. D. Rogers, A. Szarfman, D. M. Gordon, A. K. Nussier, M. Aikawa, and S. L. Hoffman. 1992. Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc. Natl. Acad. Sci. USA 89:9176-9180.
36. Sanchez, G. I., W. O. Rogers, S. Mellouk, and S. L. Hoffman. 1994. Plasmodium falciparum: exported protein-1, a blood stage antigen, is expressed in liver stage parasites. Exp. Parasitol. 79:59-62.
37. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M. D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354.
38. Scheller, •. •. Submitted for publication.
39. + T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664-666.
40. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866-9870.
41. + cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. J. Immunol. 149:966-971.
42. + T cells. J. Exp. Med. 180:353-358.
43. + cytotoxic T lymphocytes. Science 252:440-443.
44. Szarfman, A., J. A. Lyon, D. Walliker, I. Quakyi, R. J. Howard, S. Sun, W. R. Ballou, K. Esser, W. T. London, R. A. Wirtz, and R. Carter. 1988. Mature liver stages of cloned Plasmodium falciparum share epitopes with proteins from sporozoites and asexual blood stages. Parasite Immunol. 10:339-351.
45. Tine, J. A., D. E. Lanar, D. M. Smith, B. T. Wellde, P. Schultheiss, L. A. Ware, E. B. Kauffman, R. A. Wirtz, C. D. Taisne, G. S. N. Hui, S. P. Chang, P. Church, M. R. Hollingdale, D. C. Kaslow, S. Hoffman, K. P. Guito, W. R. Ballou, J. C. Sadoff, and E. Paoletti. 1996. NYVAC-Pf7: a poxvirus-vectored, multiantigen. multistage vaccine candidate for Plasmodium falciparum malaria. Infect. Immun. 64:3833-3844.
46. Villinger, F., D. Hunt, A. Mayne, M. Vuchetich, H. Findley, and A. A. Ansari. 1993. Qualitative and quantitative studies of cytokines synthesized and secreted by non-human primate peripheral blood mononucfear cells. Cytokine 5:469-479.
47. Villinger, F., S. S. Brar, A. Mayne, N. Chikkala, and A. A. Ansari. 1995. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J. Immunol. 155:3946-3954.
48. Voss, G., J. Li, K. Manson, M. Wyand, J. Sodroski, and N. L. Letvin. 1995. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys. Virology 208:770-775.
49. Voss, G., S. Nick, C. Stahl-Hennig, K. Ritter, and G. Hunsmann. 1992b. Generation of macaque B lymphoblastoid cell lines with simian Epstein-Barr-like viruses: transformation procedure, characterization of the cell lines and occurrence of simian foamy virus. J. Virol. Methods 39:185-195.
50. Walliker, D., I. A. Quakyi, T. E. Wellems, T. F. McCutchan, A. Szarfman, W. T. London, L. M. Corcoran, T. R. Burkot, and R. Carter. 1987. Genetic analysis of the human malaria parasite Plasmodium faldparum. Science 236:1661-1666.
51. + T cell- and IFN-γ-dependent elimination of infected hepatocytes. J. Immunol. 157:4061-4067.
52. Weiss, W. R., S. Mellouk, R. A. Houghten, M. Sedegah, S. Kumar, M. F. Good, J. A. Berzofsky, L. H. Miller, and S. L. Hoffman. 1990. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J. Exp. Med. 171:763-773.
53. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 85: 573-576.
54. Wizel, B., R. Houghten, P. Church, J. A. Tine, D. E. Lanar, D. M. Gordon, W. R. Ballou, A. Sette, and S. L. Hoffman. 1995. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. J. Immunol. 155:766-775.
55. Wizel, B., R. A. Houghten, K. Parker, J. E. Coligan, P. Church, D. M. Gordon, W. R. Ballou, and S. L. Hoffman. 1995. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum surface sporozoite protein 2. J. Exp. Med. 182:1435-1445.
56. World Health Organization. 1996. Malaria fact sheet no. 94. World Health Organization, Geneva, Switzerland.
57. Yasutorai, Y., S. Koening, S. S. Haun, C. K. Stover, R. K. Jackson, P. Conard, A. J. Conley, E. A. Emini, T. R. Fuerst, and N. L. Letvin. 1993. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 150:3101-3107.
58. + cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 151:5096-5105.
59. Yasutomi, Y., H. L. Robinson, S. Lu, F. Mustafa, C. Lekutis, J. Arthos, J. I. Mullins, G. Voss, K. Manson, M. Wyand, and N. L. Letvin. 1996. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J. Virol. 70:678-681.
60. Zhu, J., and M. R. Hollingdale. 1991. Structure of Plasmodium falciparum liver stage antigen-1. Mol. Biochem. Parasitol. 48:223-226.